SAFETY AND EFFICACY PROFILE OF A NOVEL RNAI-BASED THERAPY FOR POLYPOSIS

(1) Development

(2) Research, Cequent Pharmaceuticals, Cambridge, United States

(3) Research, Unite des Agents Antibacteriens, Institu Pasteur, Paris, France



This item was part of the Novel agents for treatment and prevention of colorectal cancer session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A66